(Q48022316)

7 February 2018

title

Human lupus T cells resist inactivation and escape death by upregulating COX-2. (English)

1 reference

7 February 2018

author name string

Luting Xu

1

1 reference

7 February 2018

Li Zhang

2

1 reference

7 February 2018

Yajun Yi

3

1 reference

7 February 2018

Hee-Kap Kang

4

1 reference

7 February 2018

Syamal K Datta

5

1 reference

7 February 2018

language of work or name

English

0 references

publication date

29 February 2004

1 reference

7 February 2018

published in

Nature Medicine

1 reference

7 February 2018

volume

10

1 reference

7 February 2018

page(s)

411-415

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/nm1005

exact match

0 references

cites work

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis.

1 reference

7 January 2021

Activation-induced cell death in T cells

1 reference

7 January 2021

Pathways of apoptosis in lymphocyte development, homeostasis, and disease

1 reference

7 January 2021

The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations

1 reference

7 January 2021

Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells

1 reference

7 January 2021

Cyclooxygenase-1 and -2 are expressed by human T cells

1 reference

7 January 2021

Comparative microarray analysis of gene expression during activation of human peripheral blood T cells and leukemic Jurkat T cells.

1 reference

7 January 2021

Immunological adjuvants promote activated T cell survival via induction of Bcl-3.

1 reference

7 January 2021

Delineating the genetic basis of systemic lupus erythematosus

1 reference

7 January 2021

Role of cyclooxygenase inhibitors for the prevention of colorectal cancer

1 reference

7 January 2021

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents

1 reference

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

7 January 2021

Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway

1 reference

7 January 2021

CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly.

1 reference

7 January 2021

Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis

1 reference

7 January 2021

Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.

1 reference

7 January 2021

Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function

1 reference

7 January 2021

Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1.

1 reference

7 January 2021

Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells.

1 reference

7 January 2021

Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein

1 reference

7 January 2021

Major peptide autoepitopes for nucleosome-specific T cells of human lupus

1 reference

7 January 2021

Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus.

1 reference

7 January 2021

Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1005

1 reference

7 February 2018

PubMed ID

14991050

1 reference

7 February 2018